Date: 10 - 11 December 2015
Venue: Queen Elizabeth II Conference Centre, London
Please select a day by clicking on one of the links below.
-
Friday 11 December 2015
Plenary Session 4: Hepatitis B
Hepatitis B: new treatments, new targets and possible cure
Professor Fabien Zoulim, Hospices Civils de Lyon, France
Hepatitis B/liver cancer: pathogenesis, screening and treatment
Dr David Pinato, Imperial College Healthcare NHS Trust, London, UK
Invited Lecture 1
What happens to the liver after cure?
Dr Vincent Mallet, Université Paris Descartes, France
Plenary Session 5: Hepatitis E
Epidemiology, transmission and treatment
Dr Antonio Rivero-Juárez, Instituto Maimónides de Investigación Biomédica de Córdoba, Spain
Diagnosis
Dr Harry Dalton, Royal Cornwall Hospital, Truro, UK
Invited Lecture 2
Unique issues of HCV in IVDU populations in Central and Eastern Europe
Professor Mojca Maticic, University Medical Centre Ljubljana, Slovenia
Plenary Session 6: Acute HCV, TasP and Access
Counselling, psychology and behaviour/lifestyle changes
Dr David Stuart, Chelsea and Westminster Hospital, London, UK
Recent data in treatment of acute hepatitis C
Dr Christoph Boesecke, University of Bonn, Germany
Treatment as prevention: modelling data
Dr Natasha Martin, University of California, San Diego, USA
Access to hepatitis C treatment
Mr Svilen Konov, European AIDS Treatment Group (EATG)
Debate: Should HIV-positive patients be prioritised for hepatitis C treatment?
For the motion
Dr Sanjay Bhagani, Royal Free London NHS Trust, UK
Against the motion
Professor Mark Nelson, Chelsea and Westminster Hospital, London, UK
Debate: Separate clinical trials for co-infected patients are a necessity
For the motion
Professor Karine Lacombe, Hôpital Saint-Antoine, Paris, France
Against the motion
Dr Patrick Ingiliz, Medical Center for Infectious Diseases, Berlin, Germany
Close
Dr Sanjay Bhagani Chair, EHHC Conference Steering Committee